This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Williams, R. E. Articles by Flaherty, J. T. Search for Related Content PubMed PubMed Citation Articles by Williams, R. E. Articles by Flaherty, J. T.

Circulation, Vol 83, 1006-1014, Copyright © 1991 by American Heart Association

ARTICLES

Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts

RE Williams, JL Zweier and JT Flaherty
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

BACKGROUND. Iron may play a central role in oxygen radical generation during myocardial ischemia and after reperfusion. Because conditions during ischemia may also liberate iron, we hypothesized that administration of the iron chelator deferoxamine during ischemia would result in improved functional and metabolic recovery after postischemic reperfusion. METHODS AND RESULTS. Isolated, perfused rabbit hearts were studied by phosphorus-31 nuclear magnetic resonance spectroscopy. The hearts received one of three treatments: deferoxamine at the onset of 30 minutes of global ischemia (n = 9), deferoxamine as a bolus followed by a continuous 15-minute infusion begun at reflow (n = 9), or standard perfusate (n = 7). Hearts treated with deferoxamine during ischemia showed better recovery of developed pressure than did control hearts (63.2 +/- 7.5% versus 41.2 +/- 2.9% of baseline) (p = 0.02) and better recovery of myocardial phosphocreatine content (92.4 +/- 10.3% versus 68.2 +/- 4.5% of baseline, p less than 0.05). These functional and metabolic benefits were comparable to those obtained with deferoxamine treatment during early reperfusion. In 15 additional hearts, intraischemic treatment with deferoxamine resulted in no reduction in oxygen radical concentrations as measured on frozen tissue by electron paramagnetic resonance spectroscopy at end ischemia, but the treatment eliminated the reperfusion-induced increase of free radical generation observed in control hearts (2.9 +/- 0.01 versus 7.0 +/- 0.07 microM, p less than 0.001). The magnitude of reduction was similar to that when deferoxamine was given at the onset of reflow (2.4 +/- 0.02 microM, p less than 0.001 versus control). CONCLUSIONS. These results demonstrate improved functional and metabolic recovery of myocardium treated with deferoxamine during ischemia, accompanied by a reduction in reperfusion- induced oxygen free-radical generation to the same degree as reflow treatment, confirming the importance of iron in the pathogenesis of myocardial reperfusion injury.

This article has been cited by other articles:

				J. L. Zweier and M.A. H. Talukder The role of oxidants and free radicals in reperfusion injury Cardiovasc Res, May 1, 2006; 70(2): 181 - 190. [Abstract] [Full Text] [PDF]

				Y. A. Shmist, R. Kamburg, G. Ophir, A. Kozak, V. Shneyvays, Y. J. Appelbaum, and A. Shainberg N,N,N',N'-Tetrakis(2-pyridylmethyl)-ethylenediamine Improves Myocardial Protection against Ischemia by Modulation of Intracellular Ca2+ Homeostasis J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1046 - 1057. [Abstract] [Full Text] [PDF]

				P. F. Klawitter, H. N. Murray, T. L. Clanton, and M. G. Angelos Reactive oxygen species generated during myocardial ischemia enable energetic recovery during reperfusion Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1656 - H1661. [Abstract] [Full Text] [PDF]

				B. de Valk and J. J. M. Marx Iron, Atherosclerosis, and Ischemic Heart Disease Arch Intern Med, July 26, 1999; 159(14): 1542 - 1548. [Abstract] [Full Text] [PDF]

				D. Pratico, M. Pasin, O. P. Barry, A. Ghiselli, G. Sabatino, L. Iuliano, G. A. FitzGerald, and F. Violi Iron-Dependent Human Platelet Activation and Hydroxyl Radical Formation : Involvement of Protein Kinase C Circulation, June 22, 1999; 99(24): 3118 - 3124. [Abstract] [Full Text] [PDF]

				L. D Horwitz and E. A Rosenthal Iron-mediated cardiovascular injury Vascular Medicine, May 1, 1999; 4(2): 93 - 99. [Abstract] [PDF]

				T.-S. Lee, M.-S. Shiao, C.-C. Pan, and L.-Y. Chau Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice Circulation, March 9, 1999; 99(9): 1222 - 1229. [Abstract] [Full Text] [PDF]

				A. Stamler, S. Y. Wang, D. E. Aguirre, R. G. Johnson, and F. W. Sellke Cardiopulmonary Bypass Alters Vasomotor Regulation of the Skeletal Muscle Microcirculation Ann. Thorac. Surg., August 1, 1997; 64(2): 460 - 465. [Abstract] [Full Text]

				Mohd.S. Alam, K. Ku, M. Hashimoto, S. Nosaka, Y. Saitoh, M. Yamauchi, S. Masumura, K. Nakayama, and K. Tamura Hydroxyl radical scavenging effect of nicaraven in myocardial and coronary endothelial preservation and reperfusion injury Cardiovasc Res, March 1, 1997; 33(3): 686 - 692. [Abstract] [PDF]

				J. A. Araujo, E. L. Romano, B. E. Brito, V. Parthe, M. Romano, M. Bracho, R. F. Montano, and J. Cardier Iron Overload Augments the Development of Atherosclerotic Lesions in Rabbits Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1172 - 1180. [Abstract] [Full Text]

				R. M. Odland, D. V. Poole, G. M. Lessard, D. Ehresman, and G. S. Goding Jr Fluorescein and Acidosis: Implications for Flap Perfusion Studies Arch Otolaryngol Head Neck Surg, July 1, 1992; 118(7): 712 - 716. [Abstract] [PDF]

				R. E. Kirschner and G. A. Fantini Role of Iron in Reoxygenation Injury of Postischemic Skeletal Muscle Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1992; 5(2): 69 - 83. [PDF]